Trastuzumab deruxtecan - defining a novel systemic treatment standard for HER2-positive breast cancer brain metastases? Bartsch R, Preusser M. Neuro Oncol 2024 Oct 3:noae202. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bartsch R, Preusser M. Trastuzumab deruxtecan - defining a novel systemic treatment standard for HER2-positive breast cancer brain metastases? Neuro Oncol 2024 Oct 3:noae202. doi: 10.1093.
PMID: 39360612